Despite the declining trend of Helicobacter pylori (H. pylori) prevalence around the globe,
ongoing efforts are still needed to optimize current and future regimens in view of the …

Helicobacter pylori (H. pylori) is the most common chronic bacterial infection, affecting
approximately half of the world's population. H. pylori is a Class I carcinogen according to …

Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …

Approximately half of the world's population is estimated to be infected with Helicobacter
pylori. Patients infected with this pathogen typically develop chronic active gastritis, but …

Helicobacter pylori (H. pylori) is a Gram-negative recalcitrant oncomicrobe that infects over
half of the world's population. Infection with H. pylori is the primary cause of gastric and …

The management of Helicobacter pylori (H. pylori) infection treatment differs from the
common treatment protocol for other infectious diseases. Because culture-or molecular …

Helicobacter pylori infects approximately 50% of the world's population and is considered
the major etiological agent of severe gastric diseases, such as peptic ulcers and gastric …

In this review, we discuss the problem of antibiotic resistance, heteroresistance, the utility of
cultures and antibiotic susceptibility tests in Helicobacter pylori (Hp) eradication, as well as …

Rates of antimicrobial-resistance among H. pylori strains are increasing worldwide, resulting
in declining eradication rates with current therapies, especially those containing …

Helicobacter pylori is a major human pathogen for which increasing antibiotic resistance
constitutes a serious threat to human health. Molecular mechanisms underlying this …